Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
-
Therapeutic Areas
Our expertise in the industry
FDA Approves Keytruda in Both Adjuvant and Neoadjuvant Setting in High-Risk Early-Stage TNBC In July 2021, the US FDA approved pembrolizumab (Keytruda) for high-risk, early-stage triple-negativ...
Hepion Pharma's NASH drug is set for Phase 2b after clearing the safety bar Hepion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutic drugs fo...
UNITY Biotechnology declares positive data from phase 1 clinical trial of UBX1325 in Advanced Vascular Eye Disease patients UNITY Biotechnology, Inc., a biotechnology company developing t...
Insilico Medicine raises USD 255 Million for AI drug discovery Insilico Medicine, a Hong Kong-based global leader in end-to-end artificial intelligence for target discovery, small molecule chem...
Mallinckrodt earns FDA nod for regenerative skin therapy for burns Mallinckrodt plc’s Stratagraft gained FDA approval for use in deep partial-thickness thermal burns. The company said regenerat...
Verdict for Biogen’s Long-Awaited Alzheimer’s Drug Is Finally Here The USFDA finally gave approval to eagerly-anticipated Biogen’s Drug Aducanumab for the treatment of Alzheimer’s d...
Pfizer suffers a DMD delay and halts BCMA trials amid safety woes Pfizer has paused after seeing three cases of peripheral neuropathy in an early-stage study, enrollment in a critical ana...
Arch Oncology scores USD 105 Million for anti-CD47 med in solid tumors, multiple myeloma Arch Oncology scored USD 105 million from new and old backers to expand the drug’s journey through the c...
Vertex leads in CRISPR Therapeutics partnership with USD 900 Million upfront Vertex has boosted a deal with CRISPR Therapeutics to USD 900 million upfront as the companies compete against blueb...
Lilly’s RET inhibitor Retevmo exhibits early promise in new cancer types The phase 1/2 LIBRETTO-001 trial enrolled 32 patients with 12 unique RET fusion-positive advanced cancer types, comprisi...
The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of...
The organ on a chip is a microfluidic culture device that recapitulates the complicated...
An Intraocular Lens implant is a synthetic, artificial lens placed inside the eye...
Ankylosing Spondylitis is a form of arthritis that primarily affects the spine. It caus...
Immunotherapy also called biologic therapy, is a type of cancer treatment that boosts t...
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
